INFERTILITY/ART/IVF

08:30-10:00	THE FUTURE OF IVF I	HALL A
Chairpersons	Zion Ben Rafael, Israel Joyce Harper, UK
Capsule	Expanded genetic screening: The more we can, the more we spend – what is the limit?
08:30-09:00 08:30 08:40 08:50	Debate: Preparation: Should we be using expanded genetic screening in all patients? Yes: Rita Vassena, Spain No: Tessa Homfray, UK Discussion
Capsule	Stimulation remains a basic step in IVF, can we do better?
09:00-09:30 09:00 09:10 09:20	Debate: Stimulation: We should not use more than 150 units in most patients Pro: Frank Broekmans, Netherlands Con: Norbert Gleicher, USA Discussion
Capsule	Automation in IVF can improve the lab work and maybe decrease the cost
09:30-10:00 09:30 09:40 09:50	Debate: Automation in IVF Automation in embryo culture: Laura Rienzi, Italy Automation in embryo freezing: Amir Arav, Israel Discussion

10:00-10:20

Coffee break, poster viewing and visit the exhibition

Exhibition Area

10:20-11:50	THE FUTURE OF IVF II	HALL A
Chairpersons	Zion Ben Rafael, Israel Frank Broekmans, Netherlands
Capsule	Does biology limit PGT-A’s ability to provide accurate information?
10:20-10:40	Why the PGT-A hypothesis for biological reasons, simply, cannot work Norbert Gleicher, USA
Capsule	The debate goes on, is PGT-A increase or decrease success?
10:40-11:15 10:40 10:50 11:00	HFEA recently downgraded PGT-A from “Amber” to “Red”, suggesting it has no proof. Are we all in agreement?Debate: PGT-A – more harm than good? Yes: Sebastiaan Mastenbroek, Netherlands No: Tessa Homfrey, UK Discussion
Capsule	HFEA claims that up to 74% of UK patients received some sort of add-ons – none of which received the HFEA “go ahead” light. Should we keep using these costly unproven methods?
11:15-11:50 11:15 11:25 11:35	Debate: Standard IVF vs add-on IVF – futile expense? What if the patient is willing to pay for add-ons? Pro: Scott Nelson, UK Con: Joyce Harper, UK Discussion

11:50-12:10

Break

12:10-13:10	INDUSTRY SUPPORTED SESSION	HALL A

13:10-13:40
13:10-13:40	The new approaches with oral antagonist and new algorithm Jacques Donnez, Belgium

13:40-14:30

Lunch break, poster viewing and visit the exhibition

Exhibition Area

14:30-16:30	SURGICAL TREATMENT	HALL A
Capsule	Controversial aspects of surgical procedures associated with IVF
Chairperson	Joop Laven, Netherlands
14:30-14:55	Update on Müllerian duct anomalies: Modern surgical approaches Sara Brucker, Germany
14:55-15:40 14:55 15:10 15:25	Debate: Cesarean scar defect: When to correct, by which method? Pro hysteroscopy: Eleonora Boschetti, Germany Pro laparoscopy: Olivier Donnez, Belgium Discussion
15:40-15:16:05	Fibroids must be treated prior to IVF Michelle Nisolle, Belgium
15:05-16:30	End of endometrial scratching? Ben Mol, Australia

16:30-16:50

Coffee break, poster viewing and visit the exhibition

Exhibition Area

16:50-18:20	ISMAAR SESSION	HALL A
Capsule	Almost every novelty in IVF is met with skepticism
Chairperson	Geeta Nargund, UK
16:50-17:05	Natural and mild IVF – when and how to do it Geeta Nargund, UK
17:05-17:20	The microbiome – does it really matter to ART Joop Laven, Netherlands
17:20-17:50 17:20 17:30 17:40	Debate: Duo-stim advantages and disadvantages Pro: Alberto Vaiarelli, Italy Con: Bart Fauser, Netherlands Discussion
17:50-18:20 17:50 18:00 18:10	Debate: Freeze only strategy for all? Con: Ben Mol, Australia Pro: Human Fatemi, United Arab Emirates Discussion

08:30-10:00	PCOS	HALL A
Capsule	The definition of PCO/PCOS has changed several times during the last 4 decades. Should we change it again? Despite our better understanding, the treatment remains a challenge
Chairpersons	Bart Fauser, Netherlands Ben Mol, Australia
08:30-08:55	PCOS: A brain disease? Joop Laven, Netherlands
08:55-09:20	Defining the polycystic ovary: AMH or ultrasound? Antonio La Marca, Italy
09:20-09:40	Does Cochrane reviews show any role for metformin in the management of PCOS? Thomas Tang, UK
09:40-10:00	The hypo-androgenic PCOS-like phenotype at advanced ages, one of the most frequent causes of repeat IVF failure Norbert Gleicher, USA

10:00-10:20

Coffee break, poster viewing and visit the exhibition

Exhibition Area

10:20-11:50	CONTROVERSIAL ASPECTS ROUND ADD-ONS TO IVF, LABORATORIES AND CLINICAL PROCEDURES	HALL A
Chairpersons	Laura Rienzi, Italy Zion Ben Rafael, Israel Bart Fauser, Netherlands
Discussants	Catherine Racowsky, France Norbert Gleicher, USA Antonio La Marca, Italy Joop Laven, Netherlands Verena Nordhoff, Germany
Lab procedures	Perfect timings in the embryology lab: When to denude, when to fertilize, when to culture? One or several culture media – which? Noninvasive embryo selection Genetic testing for donors.
Clinical procedures	RIF – is there a valid definition? Fresh versus frozen what to prepare ? Optimal luteal support? Aromatase inhibitors- when to use?

11:50-12:00

Break

12:00-13:30	ENDOMETRIOSIS ADENOMYOSIS	HALL A
Capsule	The concept that uterine adenomyosis and pelvic endometriosis as well as endometriotic lesions at distant sites of the body share a common pathophysiology with endometriosis was promoted almost a decade ago. What is the current thinking?
Chairpersons	Zion Ben Rafael, Israel Olivier Donnez, Belgium
12:00-12:20	Adenomyosis and deep endometriosis: Two linked diseases? Jacques Donnez, Belgium
12:20-12:40	Uterine adenomyosis: Can surgery help? Leila Adamyan, Russia
12:40-13:10 12:40 12:50 13:00	Debate: The endometrioma and the ovarian reserve: The challenge of the surgeon To operate first: Jacques Donnez, Belgium ART before operation: Edgardo Somigliana, Italy Discussion
13:10-13:30	Medical targets in endometriosis Ludwig Kiesel, Germany

13:30-14:20

Lunch break, poster viewing and visit the exhibition

Exhibition Area

14:20-15:50	HORMONAL AND MORAL ASPECTS OF HUMAN FERTILITY	HALL A
Chairperson	Edgardo Somigliana, Italy
14:20-14:40	The luteal phase in ART: Are we gaining ground? Ben Mol, Australia
14:40-15:05	Women’s biological clock, the molecular mechanisms Jennifer Gruhn, Denmark
15:05-15:25	40 years of experience with the German IVF registry Klaus Bühler, Germany
15:25-15:50	Does social egg freezing increase women’s emancipation? Guido Pennings, Belgium

15:50-16:00

Break

16:00-17:00	PREGANANCY LOSS	HALL A
Capsule	Can we prevent pregnancy loss?
Chairperson	Matthias Korell, Germany
16:00-16:20	Prevention of pregnancy loss Paul Piette, Belgium
16:20-16:40	Recurrent pregnancy loss (RPL)- what are the solutions Bettina Toth, Austria
16:40-17:00	Fertility surgery, myoma Matthias Korell, Germany